Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Concord Biotech

    Jump to

    • Stocks to Watch Today: Lenskart, LG Electronics, Federal Bank, Netweb Tech, Kernex Microsystems, Orkla, IRCON, Yatra Online, Elgi Equipments in focus on 12 February

      Stocks to Watch, 12 Feb: Stocks like LG Electronics India, Lenskart Solutions, Patanjali Foods, Amara Raja Energy & Mobility, Protean eGov Technologies, Concord Biotech, AstraZeneca Pharma, Dollar Industries, Yatra Online, NOCIL, Kirloskar Oil Engines, IRCON International, Godrej Industries, and Elgi Equipments will be in focus on February 12.

    • Concord Biotech Consolidated September 2025 Net Sales at Rs 247.06 crore, down 20.35% Y-o-Y

    • Concord Biotech Standalone September 2025 Net Sales at Rs 247.06 crore, down 20.35% Y-o-Y

    • Concord Biotech Standalone June 2025 Net Sales at Rs 203.99 crore, down 5.47% Y-o-Y

    • Concord Biotech Standalone March 2025 Net Sales at Rs 429.88 crore, up 34.77% Y-o-Y

    • Concord Biotech Consolidated March 2025 Net Sales at Rs 429.88 crore, up 34.77% Y-o-Y

    • Stocks to Watch Today: SBI, Kotak Mahindra Bank, Marico, Indian Bank, RR Kabel, AU SFB, Azad Engineering, IRCON, Concord Biotech in focus on 5 May

      Stocks to Watch, 05 May: Stocks like Avenue Supermarts, Vardhman Textiles, Voltamp Transformers, PNB Gilts, Archean Chemical Industries, Sanofi Consumer Healthcare India, Gravita India, Sunteck Realty, City Union Bank, Aether Industries, Shilpa Medicare, BSE, GOCL Corporation, Tata Motors, Indraprastha Gas, and Tata Steel will be in focus on May 5.

    • Stocks to Watch Today: Senco Gold, Phoenix Mills, Home First Finance, Concord Biotech, Sasken Tech, BPCL, IRB Infrastructure in focus on 9 April

      Stocks to Watch, 9 Apr: Stocks like Shyam Metalics and Energy, Swan Defence and Heavy Industries, Vodafone Idea, NTPC, Karnataka Bank, PNB Housing Finance, Hindustan Aeronautics, Stallion India Fluorochemicals, Route Mobile, GAIL India, NTPC Green Energy, and Sonata Software will be in focus on April 9.

    • Concord Biotech Consolidated December 2024 Net Sales at Rs 244.22 crore, up 1.42% Y-o-Y

    • Concord Biotech shares locked in 20% lower circuit after weak Q3 earnings

      Concord Biotech reported that its consolidated net profit declined 2.19 percent to Rs 75.9 crore in the December 2024 quarter.

    • Trade Spotlight: How should you trade Tata Motors, Larsen and Toubro, Amber Enterprises, Concord Biotech, Wockhardt, and others on February 5?

      The bullish sentiment is expected to sustain with the VIX reaching a one-month low. Below are some trading ideas for the near term.

    • Trade Spotlight: How should you trade Escorts Kubota, NALCO, BSE, Minda Corporation, Concord Biotech, Univastu India, and others on January 15?

      The market is expected to consolidate until it gets back above all key moving averages. Below are some trading ideas for the near term.

    • Trade Spotlight: How should you trade Marico, Concord Biotech, Pokarna, M&M, General Insurance Corporation, and others on January 10?

      Overall, the trend remains in favour of bears, given the negative bias in momentum indicators and indices trading below all key moving averages. Below are some trading ideas for the near term.

    • Trade Spotlight: How should you trade Tata Motors, Oil India, Oberoi Realty, BSE, Bajaj Finserv, and others on January 9?

      The consolidation is expected to continue as long as the frontline indices trade below all key moving averages. Below are some trading ideas for the near term.

    • Jigar Patel sees Nifty climbing towards 25,000, bets on these 3 stocks ideas for short term

      Buy Nifty Futures between 24,200-24,225, with a stop-loss of 24,050, targeting 24,500, while buy Bank Nifty Futures with a stop-loss of 52,200-52,250, with a stop-loss of 51,800, targeting 53,000.

    • Concord Biotech Consolidated September 2024 Net Sales at Rs 310.18 crore, up 18.23% Y-o-Y

    • Concord Biotech Standalone September 2024 Net Sales at Rs 310.18 crore, up 18.23% Y-o-Y

    • Concord Biotech: Strong grip on fermentation APIs stays

      Though valuations are at a premium, the company has strong earnings prospects ahead

    • Concord Biotech stock surges 12% on high volumes; climbs fresh peak

      The ongoing exploration of opportunities in the Contract Development and Manufacturing Organization (CDMO) segment is anticipated to accelerate growth for Concord Biotech, according to Choice Broking.

    • Concord Biotech Consolidated June 2024 Net Sales at Rs 215.80 crore, up 10.77% Y-o-Y

    • Concord Biotech Standalone June 2024 Net Sales at Rs 215.80 crore, up 10.77% Y-o-Y

    • Concord Biotech rallies 8% as Kotak upgrades stock to 'add', sees 11% upside

      After an impressive 220 bps EBITDA margin expansion in FY24, Concord is guiding for further improvement in FY25/26.

    • Concord Biotech Consolidated March 2024 Net Sales at Rs 318.97 crore, up 17.02% Y-o-Y

    • Concord Biotech block deal: 3.4% equity changes hands as Ontario Inc pares stake

      As per reports, the residual stake held by Ontario Inc post the block deal could be locked in for a period of 90 days before the firms could pare any further equity. Ontario Inc held a 5.39 percent stake in Concord Biotech as of the March quarter.

    • Ontario Inc to sell 3.4% in Concord Biotech, deal size worth Rs 468.40 crore: CNBC-TV18

      The seller entity will have residual stake of two percent in the company after the transaction

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347